ANGPTL4 and hypertriglyceridemia: Since ANGPTL3, ANGPTL4, and ANGPTL8 are all LPL inhibitors, the absence of anyone of them would break the balance of triglyceride metabolism in turn would lead to hypotriglyceridemia or hypertriglyceridemia.